IDHC vs. GDR, OCTP, DEMG, N4P, PYC, NFX, TRLS, HELD, VAL, and BNR
Should you be buying Integrated Diagnostics stock or one of its competitors? The main competitors of Integrated Diagnostics include genedrive (GDR), Oxford Cannabinoid Technologies (OCTP), Deltex Medical Group (DEMG), N4 Pharma (N4P), Physiomics (PYC), Nuformix (NFX), Trellus Health (TRLS), Hellenic Dynamics (HELD), ValiRx (VAL), and Burning Rock Biotech (BNR). These companies are all part of the "medical" sector.
Integrated Diagnostics (LON:IDHC) and genedrive (LON:GDR) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, profitability, dividends, community ranking, earnings, valuation, institutional ownership and media sentiment.
Integrated Diagnostics has a beta of 0.54, meaning that its stock price is 46% less volatile than the S&P 500. Comparatively, genedrive has a beta of 0.04, meaning that its stock price is 96% less volatile than the S&P 500.
39.5% of Integrated Diagnostics shares are held by institutional investors. Comparatively, 1.2% of genedrive shares are held by institutional investors. 27.1% of Integrated Diagnostics shares are held by insiders. Comparatively, 52.1% of genedrive shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
In the previous week, genedrive had 3 more articles in the media than Integrated Diagnostics. MarketBeat recorded 3 mentions for genedrive and 0 mentions for Integrated Diagnostics. Integrated Diagnostics' average media sentiment score of 0.00 beat genedrive's score of -0.16 indicating that Integrated Diagnostics is being referred to more favorably in the media.
genedrive received 186 more outperform votes than Integrated Diagnostics when rated by MarketBeat users. Likewise, 72.67% of users gave genedrive an outperform vote while only 65.12% of users gave Integrated Diagnostics an outperform vote.
Integrated Diagnostics has a net margin of 12.38% compared to genedrive's net margin of 0.00%. Integrated Diagnostics' return on equity of 16.89% beat genedrive's return on equity.
Integrated Diagnostics has higher revenue and earnings than genedrive. genedrive is trading at a lower price-to-earnings ratio than Integrated Diagnostics, indicating that it is currently the more affordable of the two stocks.
Summary
Integrated Diagnostics beats genedrive on 10 of the 15 factors compared between the two stocks.
Get Integrated Diagnostics News Delivered to You Automatically
Sign up to receive the latest news and ratings for IDHC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding IDHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Integrated Diagnostics Competitors List
Related Companies and Tools
